Crinetics Pharmaceuticals, Inc. (CRNX)
84.79
+0.10
(+0.12%)
USD |
NASDAQ |
Aug 24, 16:00
84.79
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals 1 Year Total Returns (Daily) : 188.1% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 188.1% |
| August 20, 2026 | 191.1% |
| August 19, 2026 | 187.8% |
| August 18, 2026 | 184.9% |
| August 17, 2026 | 175.9% |
| August 14, 2026 | 185.3% |
| August 13, 2026 | 180.6% |
| August 12, 2026 | 196.6% |
| August 11, 2026 | 208.1% |
| August 10, 2026 | 213.4% |
| August 07, 2026 | 201.6% |
| August 06, 2026 | 194.1% |
| August 05, 2026 | 187.3% |
| August 04, 2026 | 197.2% |
| August 03, 2026 | 200.9% |
| July 31, 2026 | 192.1% |
| July 30, 2026 | 186.1% |
| July 29, 2026 | 186.6% |
| July 28, 2026 | 176.8% |
| July 27, 2026 | 170.6% |
| July 24, 2026 | 175.3% |
| July 23, 2026 | 170.0% |
| July 22, 2026 | 174.8% |
| July 21, 2026 | 171.1% |
| July 20, 2026 | 169.6% |
| Date | Value |
|---|---|
| July 17, 2026 | 154.0% |
| July 16, 2026 | 163.0% |
| July 15, 2026 | 163.6% |
| July 14, 2026 | 153.5% |
| July 13, 2026 | 162.0% |
| July 10, 2026 | 161.3% |
| July 09, 2026 | 158.6% |
| July 08, 2026 | 184.3% |
| July 07, 2026 | 187.4% |
| July 06, 2026 | 41.04% |
| July 02, 2026 | 43.44% |
| July 01, 2026 | 36.05% |
| June 30, 2026 | 30.11% |
| June 29, 2026 | 23.30% |
| June 26, 2026 | 22.37% |
| June 25, 2026 | 15.06% |
| June 24, 2026 | 16.94% |
| June 23, 2026 | 20.06% |
| June 22, 2026 | 17.31% |
| June 18, 2026 | 17.61% |
| June 17, 2026 | 15.88% |
| June 16, 2026 | 12.18% |
| June 15, 2026 | 10.54% |
| June 12, 2026 | 7.15% |
| June 11, 2026 | 3.71% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Vertex Pharmaceuticals, Inc. | 37.89% |
| Johnson & Johnson | 54.80% |
| Eli Lilly & Co. | 77.98% |
| Pfizer Inc. | 16.73% |
| Bristol Myers Squibb Co. | 44.96% |